Invention Grant
- Patent Title: Carbohydrate-glycolipid conjugate vaccines
-
Application No.: US14385948Application Date: 2013-03-19
-
Publication No.: US10588962B2Publication Date: 2020-03-17
- Inventor: Peter H. Seeberger , Pierre Stallforth , Gennaro De Libero , Marco Cavallari
- Applicant: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. , UNIVERSITÄTSSPITAL BASEL
- Applicant Address: DE Munich CH Basel
- Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.,UNIVERSITÄTSSPITAL BASEL
- Current Assignee: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.,UNIVERSITÄTSSPITAL BASEL
- Current Assignee Address: DE Munich CH Basel
- Agency: Maier & Maier, PLLC
- Priority: EPPCT/EP2012/054848 20120319; EPPCT/EP2012/002277 20120526
- International Application: PCT/EP2013/055719 WO 20130319
- International Announcement: WO2013/139803 WO 20130926
- Main IPC: A61K39/39
- IPC: A61K39/39 ; A61K39/09 ; C07K16/12 ; A61K39/00

Abstract:
The present invention relates to the field of synthesizing and biologically evaluating of a novel class of carbohydrate-based vaccines. The new vaccines consist of a multi-modular structure which allows applying the vaccine to a whole variety of pathogenes. This method allows preparing vaccines against all pathogens expressing immunogenic carbohydrate antigens. As conjugation of antigenic carbohydrates to proteins is not required the conjugate vaccine is particularly heat stable. No refrigeration is required, a major drawback of protein-based vaccines.
Public/Granted literature
- US20150238597A1 CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES Public/Granted day:2015-08-27
Information query